S&P Global reports Q1 results on May 12 with the analyst community unusually aligned — and meaningfully above where the stock is trading.
The bullish conviction among Wall Street firms is the clearest angle heading into this print. The mean price target runs at $534, roughly 27% above Friday's close of $420.12, and recent analyst moves have been additive rather than cautious. JP Morgan raised its target to $550 from $530 on April 29, maintaining Overweight, while Mizuho nudged its own target up to $554 this week. Morgan Stanley trimmed to $556 from $580 back in early April but held its Overweight rating — the direction of travel from bellwether names is unmistakably constructive even as individual targets have been adjusted. The consensus reflects what bulls focus on: accelerating growth in the Ratings segment, a 26% year-over-year rise in average ETF assets under management, and the prospect of further margin expansion as integration work from the IHS Markit merger concludes. Bears counter with the more uncomfortable detail — Q4 results and 2026 guidance disappointed, Market Intelligence margins underwhelmed, and AI disruption risk continues to weigh on sentiment in the financial data space. Higher interest expenses and a steeper tax rate add friction to the near-term earnings path.
Short selling tells a different story — bears are not pressing the position. Short interest is just above 1% of the free float, and has fallen roughly 7% over the past month. Availability in the lending market is exceptionally loose, with borrow costing less than 0.32% annualised and availability far from constrained. The ORTEX short score sits at 27.9, placing this firmly in the low-pressure range. There is no short-side crowding to speak of.
Options positioning is equally muted. The put/call ratio is running at 0.76 — essentially in line with its 20-day average of 0.76 and a z-score close to zero. The 52-week range on the PCR runs from 0.54 to 1.24, and the current reading is nowhere near either extreme. Options traders are not hedging aggressively nor speculating with unusual force.
The most genuinely interesting data point sits in the insider register. CEO Martina Cheung purchased nearly $1 million of stock on April 29, days after the last quarterly release. A divisional CEO added $1.08 million on May 1. Net insider activity over the past 90 days totals more than $12.6 million on the buy side. That cluster of buying at current price levels — from the company's most senior figures — is a signal that management is comfortable owning the stock in the $420–$435 range, despite the stock trading roughly 21% below the February highs.
Tuesday's print will test whether the Ratings segment can sustain the momentum that has kept analysts constructive, and whether Market Intelligence margins have stabilised enough to quiet the bear case built around margin disappointment and AI displacement risk.
See the live data behind this article on ORTEX.
Open SPGI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
